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ABSTRACT
Aims: Understanding type 2 diabetes mellitus is
critical for designing effective diabetes prevention
policies in Qatar and the Middle East.
Methods: Using the Qatar 2012 WHO STEPwise
approach to surveillance survey, a subsample of 1224
Qatari participants aged 18–64 years was selected.
Subjects had their fasting blood glucose levels tested,
had not been diagnosed with or treated for diabetes,
had a fasting time >12 hours and were not pregnant.
We applied a hypothesized structural equation model
(SEM) to assess sociodemographic, behavioral,
anthropometric and metabolic variables affecting
persons with type 2 diabetes mellitus.
Results: There is a direct effect of triglyceride levels
(0.336) and body mass index (BMI) (0.164) on
diabetes status. We also found that physical activity
levels negatively affect BMI (−0.148) and positively
affect high-density lipoprotein (HDL) (0.106);
sociodemographic background negatively affects diet
(−0.522) and BMI (−0.352); HDL positively affects
total cholesterol (0.230) and has a negative effect on
BMI (−0.108), triglycerides (−0.128) and waist
circumference (−0.104). Diet has a positive effect on
triglycerides (0.281) while family history of diabetes
negatively affects total cholesterol (−0.104). BMI has a
positive effect on waist circumference (0.788) and
mediates the effects of physical activity over diabetes
status (−0.028). BMI also mediates the effects that
sociodemographic factors (−0.058) and physical activity
(−0.024) have on diabetes status. BMI and HDL
(−0.002) together mediate the effect of physical activity
on diabetes status and similarly HDL and tryglycerides
(−0.005) also mediate the effect of physical activity on
diabetes status. Finally diet and tryglycerides mediate
the effects that sociodemographic factors have on
diabetes status (−0.049).
Conclusions: This study’s main finding is that
triglyceride levels and BMI are the main variables directly
affecting diabetes status in the Qatari population.
INTRODUCTION
The global epidemic of type 2 diabetes melli-
tus and other non-communicable diseases
(NCDs) have affected the Middle East and
Northern Africa particularly severely.1–6
According to the WHO, the Eastern
Mediterranean region has the second highest
regional prevalence of type 2 diabetes in the
world at 9.3%.7 Diabetes attributable deaths
are expected to increase by two-thirds
between 2008 and 2030 and the global preva-
lence of pre-diabetes will increase to 470
million by 2030.8–10 These consequences will
predominantly affect Northern Africa and the
Middle East, where the prevalence of type 2
diabetes is expected to rise to 10.8% by 2030.7
One of the Middle Eastern countries most
affected by the diabetes epidemic is Qatar,
where the STEPwise approach to surveillance
(STEPS) survey reported prevalence of dia-
betes for Qatari nationals was 16.7% in
2012.11 12
The high and growing prevalence of type 2
diabetes in the region has heightened the
need for effective early interventions that
tackle the disease’s long-term harmful effects
Key messages
What is already known about this subject?
▪ Diabetes and metabolic disease are serious
public health challenges in Qatar, and carry an
increasing burden of disease to the health
systems in the WHO East Mediterranean region.
What are the new findings?
▪ This study shows that BMI and triglyceride levels
are the main variables affecting diabetes status
in Qatari nationals mediated by levels of physical
activity, sociodemographic variables like educa-
tion level and marital status and dietary patterns.
How might these results change the focus of
research or clinical practice?
▪ The results of this study show the potential that
behavioral and metabolic interventions might
have in reducing the impact that diabetes has in
Qatar's health system.
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at both individual and health system levels.5 13–18 There is
a strong link between anthropometric and metabolic risk
factors and both pre-diabetes and type 2 diabetes. Early
detection of individuals at risk for developing type 2 dia-
betes is an effective tool for reducing the prevalence and
impact of the disease. In addition, early detection is crit-
ical to helping deﬁne an individual’s subsequent risk for
developing type 2 diabetes.12 19 20
The disease pathway of type 2 diabetes is deﬁned by
stepwise increases in blood glucose level and consists of
three stages. The ﬁrst stage, known as normoglycemia,
encompasses the normal glucose range of 65–99 mg/dL.
The second stage, termed pre-diabetes, occurs in people
with blood glucose levels between 100 and 126 mg/dL.21
The ﬁnal stage is the full expression of a diabetic state
and is deﬁned by a blood glucose level >126 mg/dL.22
Transitioning to type 2 diabetes is associated with the
simultaneous presence of increased insulin resistance and
β-cell dysfunction associated with an abnormal lipid
proﬁle. This dynamic pathway is theorized to be closely
linked to abnormal glucose levels that are present once
type 2 diabetes has been diagnosed.9 23–27 These abnor-
malities are hypothesized to start before glucose changes
are detectable, suggesting that early lifestyle and behav-
ioral interventions in high-risk individuals are effective at
reducing the risk of developing type 2 diabetes.9 23–27 For
this reason, WHO recommends type 2 diabetes screening
in non-clinical settings for behavioral, metabolic and car-
diovascular risk factors that lead normoglycemic subjects
ﬁrst to a prediabetic state and then to type 2 diabetes.21
The WHO has identiﬁed the following risk factors for
type 2 diabetes: obesity, high blood pressure, smoking,
lipid abnormalities, family history of diabetes and low
consumption of fruit and vegetables.28 Despite the high
prevalence of type 2 diabetes in the Middle East, few
studies have examined type 2 diabetes in a Middle
Eastern context. We propose using a structural equation
model (SEM) as a novel method to test a hypothesized
model of cross-sectional variables affecting diabetes status
in the Qatari population, using data from a WHO nation-
ally representative survey of Qatari nationals. Examining
type 2 diabetes in this region using a SEM has the beneﬁt
of allowing us to hypothesize and model speciﬁc regional
disease frameworks linked to particular metabolic proﬁles
and behavioral patterns. Analysis with SEM permits us to
deﬁne local interactions of sociodemographic, behavioral,
anthropometric and metabolic variables in terms of
direct effects and indirect (ie, mediator) effects on dia-
betes status.28 Unlike traditional regression models, SEM
can simultaneously assess all relevant regression pathways
as either independent and/or dependent factors that
play a role in type 2 diabetes.28
RESEARCH DESIGN AND METHODS
The Qatar STEPS survey
WHO developed the STEPS to support countries in
building and strengthening their capacity to conduct
NCD surveillance programs.29–33 The STEPS tool is a
risk factor assessment instrument that gathers informa-
tion at three different levels. The ﬁrst level gathers
demographic and behavioral risk factor information
using a questionnaire; the second collects physical mea-
surements in a household setting; the third collects
fasting blood samples for biochemical tests.34
In this framework, risk factors were deﬁned as any
attribute, characteristic or exposure that would increase
an individual’s probability of developing a chronic NCD.
According to the WHO World Health Report 2002, the
major identiﬁed behavioral risk factors for developing
type 2 diabetes are tobacco use, harmful alcohol use,
unhealthy diet (low fruit and vegetable consumption)
and physical inactivity,35 while the major biological risk
factors are overweight and obesity, raised blood pressure,
raised fasting blood glucose (FBG), abnormal blood
lipids and raised total cholesterol.35 The above-
mentioned behavioral and biological risk factors are cap-
tured in the STEPS risk factor instrument.
The STEPS survey conducted in Qatar in 2012 was a
nationally representative survey that included only
Qatari nationals between the ages of 18 and 64 years.12
This STEPS survey uses a sample frame consisting exclu-
sively of Qatari households in order to assess only the
stable population of Qatar.12 The sample size was 2850
Qatari citizens and the overall non-response rate was
12%, resulting in 2496 Qatari citizens being interviewed.
FBG levels and exclusion criteria
Participants were included in our study if they had a
FBG test performed, no lifetime diagnosis of diabetes,
were not pregnant during the test and had not eaten
during the previous 12 hours or taken any form of dia-
betes or dyslipidemia medication. Based on these cri-
teria, 1133 participants were included in our analyses.
According to international standards,21 we deﬁned sub-
jects with a FBG above 126 mg/dL as having type 2 dia-
betes and those with a FBG between 100 and 125 mg/dL
as prediabetic. Normoglycemia, was deﬁned as a FBG
between 65 and 99 mg/dL for the purpose of building
our hypothetical model.21
Variables and effects assessed
We selected the sociodemographic, behavioral,
anthropometric and metabolic variables to be included
in our SEM based on a literature review of previous the-
oretical models of diabetes transition.28 36–38 We assessed
23 variables including: sex, age, highest level of educa-
tion (deﬁned as no formal schooling, less than primary
school, primary school completed, preparatory school
completed, secondary school completed, college/univer-
sity completed and postgraduate degree), marital status
(never married, currently married, divorced and
widowed), consanguinity between father and mother
(yes or no), smoking status (was deﬁned as positive if a
subject ever smoked), body mass index (BMI) (<18.5,
18.5–24.9, 25–29.9, 30–40, >40), family history of
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diabetes, waist circumference (male: <94, 94–102,
>102 cm; female:<80, 80–88, >88 cm), blood pressure
(either >135mm Hg systolic and/or >85 mm Hg diastolic
or current treatment or diagnosis of high blood pres-
sure), FBG (<100 mg/dL, 100–125 mg/dL, >125 mg/
dL), HDL (<40, 40–60, >60 mg/dL), triglycerides (<150,
150–200, >200 mg/dL), total cholesterol (<200, 200–240,
>240 mg/dL) and physical activity (average self-reported
hours per week of vigorous-intensity work and sports
activities, moderate-intensity activity for sports and work,
and walking). We also included measures of dietary
quality based on the STEPS tool.35 These included fruit
and vegetable intake using the 7-day average recall
dietary assessment of the STEPS questionnaire.29 34 39
With these two dietary components we created Healthy
Eating Index—2010 (HEI) scores.40 The HEI is a
measure of diet quality that is independent of quantity
and that can be used to assess compliance with the US
Dietary Guidelines for Americans and monitor changes
in dietary patterns.40 It is based on a score between 0 and
5, where 5 is the highest quality diet. We also included as
a measure of dietary quality the number of days per week
the participants ate out of their homes and the self-
reported weekly frequency of fast food consumption.
Statistical analysis and SEM
SEM and factor analysis of diet, physical activity and
sociodemographic characteristics were used to describe
the sociodemographic, latent behavioral, anthropomet-
ric and metabolic variables affecting normoglycemia,
pre-diabetes and diabetes based on the model used by
Bardenheier et al.28 SEM correlates groups of interre-
lated variables into a single factor or latent construct
involving path analysis, including the direct effects of
factors and correlations among them.28 41 42 SEMs are
often best understood using a graphic where direct
effects are depicted as vectors stemming from an inde-
pendent variable (exposure) and pointing towards a
dependent variable (outcome). A confounder, accord-
ing to the use of these directed acyclic graphs, is
depicted as a variable with direct effects on both the
exposure and the dependent variable.28 Correlations
between the measurement errors of two variables are
represented by two-headed curving arrows, in which
case only the measurement error terms were deﬁned as
correlated.41 42
Analyses proceeded in two stages. First, congruent
with our hypotheses, we created and conﬁrmed the a
priori factor structure. We conﬁrmed these latent behav-
ioral constructs for physical activity, diet and sociodemo-
graphic variables. An assumption of this analysis is that
an underlying unmeasured variable is identiﬁed by the
shared variance of the observed variables.28 41 42 The
constellations of factors that comprise self-reported phys-
ical activity, diet and sociodemographic patterns may best
be modeled in terms of their shared variance rather
than to the individual account of the underlying im-
measurable source.28 41 42 Second, we proceeded to test
the hypothesized model with special emphasis on obser-
ving the linkage between latent behavioral, sociodemo-
graphic, anthropometric and biological variables, as well
as the direct effects and correlations that deﬁne them.
The aim of this hypothesized model was to assess
modiﬁable behavioral and metabolic factors such as
physical activity, diet, lipids, obesity and high blood pres-
sure together with sociodemographic variables that
inﬂuence normoglycemia, pre-diabetes and type 2 dia-
betes in Qatar. Since age, sex and consanguinity are
strong confounders that are linked to other factors in
the model, their effects, while included in our model,
are not shown in the ﬁnal graphic.
Our hypothesized model is depicted in ﬁgure 1. We
hypothesized 77 paths that directly and/or indirectly
affect diabetes status. These 77 paths emanate from the
21 observed variables, three latent variables and two cov-
ariates. It is important to note the data’s inherent tem-
porality resultant from the STEPS survey’s design which
is of cross-sectional nature. In this case, sex and family
history of diabetes are determined at birth, while other
variables such as age are a function of birth date.
Moreover, physical activity and dietary intake were
reported for the 7-day period prior to the survey and it
is assumed that these behavioral reports were routine
patterns.18 A detailed description of our model can be
found in the online supplementary material.
We used STATA V.13.1 for data management and
descriptive statistics. In addition, we employed Mplus
V.7.31 software for conﬁrmatory factor analysis and
testing the structural model. We accounted for the
complex cross-sectional survey design of STEPS by
including the sample weights in our analyses. We
applied a weighted least squares means and variance
adjusted (WLSMV) model ﬁt, designed for categorical
data analysis in Mplus.43 In the WLSMV analysis, SEs for
the standardized path coefﬁcients are not computed.
Consequently, we only report the standardized estimates
and the ﬁt statistics of the models. The indices of the
statistical model used to ﬁt the data were the standard
criteria for evaluating SEM models and were reported
throughout. For the purpose of this study they include
the Comparative Fit Index (CFI) >0.90, root mean
square error of approximation (RMSEA) <0.08 and
weighted root mean square (WRMR) ≈1. Modiﬁcation
indices were used to evaluate and select speciﬁc paths
for the best-ﬁtting model. p <0.05 were considered statis-
tically signiﬁcant.
RESULTS
Descriptive statistics
Among the 1133 participants, 960 (84.7%) were consid-
ered normoglycemic, 136 (12%) were prediabetic and
37 (3.3%) had FBG values in the diabetes range
(p=0.536). Compared with those with normal glucose, at
the p<0.05 level, individuals with type 2 diabetes or pre-
diabetes were more likely to be between 45 and 55 years
BMJ Open Diabetes Research and Care 2016;4:e000231. doi:10.1136/bmjdrc-2016-000231 3
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of age (24.32% and 30.37% vs 14.93%, p=0.000), be
obese (37.83% and 47.05% vs 32.6%, p=0.000) or mor-
bidly obese (21.62% and 13.23% vs 8.35%, p=0.000),
have no formal schooling (13.51% and 8.82% vs 3.96%,
p=0.007), with a considerably greater proportion of indi-
viduals with type 2 diabetes with less than a primary
school education in comparison to those people with
pre-diabetes or normoglycemia (10.81% vs 2.94% and
3.64%, p=0.007). They were also less likely to never have
been married (10.81% and 18.38% vs 25.2%, p=0.025)
and more likely to be divorced (10.81% and 4.41% vs
4.79%, p=0.025). At this same signiﬁcance level, it was
also found that a greater proportion of women with type
2 diabetes and pre-diabetes had a large waist circumfer-
ence in comparison to women with normoglycemia
(78.94% and 64% vs 51.76%, p=0.036). This was also the
case for men (76.47% and 57.14% vs 43.98%, p=0.03).
All the descriptive statistics are reported in table 1.
Diet and physical activity
When dietary patterns were analyzed we found that
people with type 2 diabetes had lower mean vegetable
HEI scores (6.53) than individuals with pre-diabetes
(8.02) or normoglycemia (7.94) (p=0.032). In contrast,
individuals with type 2 diabetes showed no difference in
mean fruit HEI scores (4.63) compared to individuals
with pre-diabetes (5.23) or normoglycemia (4.88)
(p=0.51). We found that subjects with normoglycemia
on average ate out (2.08) the same amount of times per
week as subjects with pre-diabetes (1.89) or type 2 dia-
betes (1.62) (p=0.37). Average weekly fast food con-
sumption was similarly not signiﬁcantly different
between subjects, with normoglycemic individuals eating
fast food 1.62 times per week, patients who are predia-
betic subjects eating 1.55 times and patients who are dia-
betic subjects eating 1.61 times (p=0.88).
For the physical activity measures, we found that there
was no statistically signiﬁcant difference between subjects
with type 2 diabetes, pre-diabetes and normoglycemia
regarding their weekly time spent performing vigorous
physical activity at work (4.01, 1.46 and 1.49 hours/week,
respectively; p=0.059), moderate physical activity at work
(3.42, 3.94 and 3.97 hours/week; p=0.95), vigorous phys-
ical activity through sports (0.12, 0.48 and 1.07 hours/
week; p=0.19) or moderate physical activity through
sports (0.59 vs 0.99 and 1.27 hours/week; p=0.25). In
addition, subjects with type 2 diabetes walk the same
amount compared to subjects with pre-diabetes or
normoglycemia (6.53, 4.33 and 4.05 hours/week; p=0.2).
All diet and physical activity data are reported in table 2.
SEM and path analysis
The hypothesized model ﬁtted the data well (CFI 0.920;
RMSEA 0.052; WRMR 1.654). Non-signiﬁcant paths were
Figure 1 Hypothesized factors for diabetes in the STEPwise approach to surveillance 2012 survey—Qatar among adults aged
18–64 years. Ellipse indicates latent, unobservable constructs (to be identified using factor analysis); box indicates observed
variable; straight line with one arrowhead denotes direct effect.
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Table 1 Characteristics of the STEPS participants according to normal glucose status, pre-diabetes and diabetes
Characteristic
Normal Pre-diabetes Diabetes Total p value
Pearson’s
χ2n % 95% CI n % 95% CI n % 95% CI n % 95% CI
Sex 0.536
Male 371 38.6 35.6% to 41.8% 57 41.9 33.8% to 50.5% 17 45.9 30.1% to 62.6% 445 39.3 36.5% to 42.2%
Female 589 61.4 58.2% to 64.4% 79 58.1 49.5% to 66.2% 20 54.1 37.4% to 69.8% 688 60.7 57.8% to 63.5%
Age 0.000
18–25 200 21.0 18.6% to 23.7% 20 14.8 9.7% to 21.9% 2 5.4 1.2% to 20.3% 222 19.8 17.5% to 22.2%
25–35 238 25.0 22.4% to 27.9% 23 17.0 11.5% to 24.4% 10 27.0 14.7% to 44.2% 271 24.1 21.7% to 26.7%
35–45 306 32.2 29.3% to 35.2% 41 30.4 23.1% to 38.7% 12 32.4 18.9% to 49.7% 359 31.9 29.3% to 34.8%
45–55 142 14.9 12.8% to 17.3% 41 30.4 23.1% to 38.7% 9 24.3 12.8% to 41.4% 192 17.1 15.0% to 19.4%
55–65 65 6.8 5.4% to 8.6% 10 7.4 3.9% to 13.3% 4 10.8 3.9% to 26.5% 79 7.0 5.7% to 8.7%
Marital status 0.025
Never married 242 25.2 22.6% to 28.1% 25 18.4 12.8% to 25.9% 4 10.8 3.9% to 26.5% 271 23.9 21.5% to 26.5%
Currently married 652 67.9 64.9% to 70.8% 100 73.5 65.4% to 80.3% 26 70.27 53.0% to 83.2% 778 68.7 65.9% to 71.3%
Divorced 46 4.78 3.6% to 6.3% 6 4.4 1.9% to 9.6% 4 10.81 3.9% to 26.5% 56 4.9 3.8% to 6.4%
Widowed 20 2.1 1.3% to 3.2% 5 3.7 1.5% to 8.6% 3 8.10 2.4% to 23.3% 28 2.5 1.7% to 3.6%
Consanguinity between mother
and father
0.503
Yes 353 36.8 33.8% to 39.9% 45 33.1 25.6% to 41.5% 11 29.7 16.8% to 46.9% 409 36.1 33.3% to 38.9%
No 607 63.2 60.1% to 66.2% 91 66.9 58.5% to 74.4% 26 70.3 53.0% to 83.2% 724 63.9 61.1% to 66.7%
Education 0.007
No formal schooling 38 3.9 2.9% to 5.4% 12 8.8 5.0% to 14.9% 5 13.5 5.5% to 29.6% 55 4.9 3.7% to 6.3%
Less than primary school 35 3.6 2.6% to 5.0% 4 2.9 1.1% to 7.7% 4 10.8% 3.9% to 26.5% 43 3.8 2.8% to 5.1%
Primary school completed 74 7.7 6.2% to 9.6% 12 8.8 5.0% to 14.9% 4 10.8 3.9% to 26.5% 90 7.9 6.5% to 9.7%
Preparatory school
completed
119 12.4 10.5% to 14.7% 24 17.6 12.1% to 25.1% 5 13.5 5.5% to 29.6% 148 13.1 11.2% to 15.2%
Secondary school completed 341 34.8 31.9% to 37.9% 34 25.0 18.4% to 33.1% 12 32.4 18.9% to 49.7% 380 33.6 30.9% to 36.4%
College/university completed 323 33.7 30.8% to 36.7% 44 32.4 24.9% to 40.8% 7 18.9 8.9% to 35.6% 374 33.0 30.4% to 35.8%
Postgraduate degree 36 3.8 2.7% to 5.12% 6 4.4 1.9% to 9.6% 0 0.0 0.0% 42 3.7 2.78% to 4.9%
BMI 0.000
<18.5 35 3.7 2.6% to 5.1% 3 2.2 0.7% to 6.7% 0 0.0 0 39 3.4 2.5% to 4.6%
18.5–24.9 250 26.1 23.4% to 3.0% 18 13.2 8.5% to 20.1% 6 16.2 7.2% to 32.6% 275 24.2 21.8% to 26.8%
25.0–29.9 280 29.3 26.5% to 32.2% 33 24.3 17.7% to 32.3% 9 24.3 12.8% to 41.4% 323 28.5 25.9% to 31.2%
30–40 312 32.6 29.7% to 35.6% 64 47.1 38.7% to 55.6% 14 37.83 23.3% to 54.9% 389 34.5 31.8% to 37.3%
>40 80 8.4 6.8% to 10.3% 8 13.2 8.5% to 21.1% 8 21.6 10.8% to 38.5% 106 9.4 7.8% to 11.2%
Waist circumference
Male 0.03
<94 127 34.7 29.9% to 39.7% 12 21.4 12.4% to 34.5% 2 11.8 2.5 to 4.09 141 32.1 27.9% to 36.7%
94–102 78 21.3 17.4% to 25.8% 12 21.4 12.4% to 34.5% 2 11.8 2.5 to 4.09 92 20.9 17.4% to 25.0%
>102 161 43.9 38.9% to 49.1% 32 57.1 43.6% to 69.7% 13 76.5 48.2% to 91.9% 206 46.9 42.3% to 51.6%
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BM
J
Open
Diabetes
Research
and
Care
2016;4:e000231.doi:10.1136/bm
jdrc-2016-000231
5
E
p
id
e
m
io
lo
g
y
/h
e
a
lth
s
e
rv
ic
e
s
re
s
e
a
rc
h
Table 1 Continued
Characteristic
Normal Pre-diabetes Diabetes Total p value
Pearson’s
χ2n % 95% CI n % 95% CI n % 95% CI n % 95% CI
Female 0.036
<80 169 29.8 26.1% to 33.7% 15 20.0 12.3% to 30.8% 1 5.3 0.0% to 33.8% 185 27.9 24.7% to 31.5%
80–88 105 18.5 15.5% to 21.9% 12 16.0 9.2% to 26.4% 3 15.8 4.6% to 42.2% 120 18.1 15.4% to 21.3%
>88 294 51.8 47.6% to 55.9% 48 64.0 52.3% to 74.2% 15 78.9 52.7% to 92.7% 357 53.9 50.1% to 57.7%
Triglycerides (mg/dL) 0.000
<150 843 88.7 86.6% to 90.6% 111 82.8 75.4% to 88.4% 17 45.9 30.1% to 62.6% 971 86.6 84.5% to 88.5%
150–200 69 7.3 5.8% to 9.1% 15 11.2 6.8% to 17.8% 9 24.3 12.8% to 41.4% 93 8.3 6.8% to 10.1%
>200 38 4.0 2.9% to 5.5% 8 5.9 2.9% to 11.6% 11 29.7 16.8% to 46.9% 57 5.1 3.3% to 6.5%
Family history of diabetes 0.746
Yes 650 67.7 64.7% to 70.6% 88 64.7 56.2% to 72.4% 24 64.9 47.6% to 78.9% 762 67.3 64.5% to 69.9%
No 310 32.3 29.4 to 35.3% 48 35.3 27.6% to 43.8% 13 35.1 21.1% to 52.4% 371 32.7 30.1% to 35.5%
Blood pressure (mm/Hg) 0.229
<135/80 610 63.6 60.5% to 66.6% 81 59.6 51.0% to 67.6% 19 51.4 34.9% to 67.5% 710 62.7 59.9% to 65.5%
>135/80 and/or on
medication
349 36.4 33.3% to 39.5% 55 40.4 32.4% to 48.9% 18 48.6 32.5% to 65.1% 422 37.3 34.5% to 40.1%
HDL cholesterol (mg/dL) 0.146
<40 257 26.9 24.1% to 29.8% 36 26.5 19.7% to 34.6% 17 45.9 30.1% to 62.6% 310 27.4 24.9% to 30.1%
40–60 418 43.7 40.6% to 46.8% 61 44.9 36.6% to 53.4% 13 35.1 21.1% to 52.4% 492 43.5 40.7% to 46.5%
>60 282 29.5 26.7% to 32.4% 39 28.7 21.6% to 36.9% 7 18.9 8.9% to 35.6% 328 29.0 26.4% to 31.7%
Total cholesterol (mg/dL) 0.004
<200 835 87.4 85.2% to 89.4% 112 82.4 74.9% to 87.9% 28 75.7 58.6% to 87.3% 835 86.4 84.3% to 88.3%
200–240 102 10.7 8.9% to 12.8% 15 11.0 6.7% to 17.6% 8 21.6 10.8% to 38.5% 102 11.1 9.4% to 13.1%
>240 18 1.9 1.2% to 2.9% 9 6.6 3.5% to 12.3% 1 2.7 0.3% to 18.3% 18 2.5 1.7% to 3.6%
Smoking 0.512
No 169 82.4 79.9% to 84.7% 22 83.8 76.5% to 89.2% 9 75.7 58.6% to 87.2% 200 82.3 80% to 84.5%
Yes 791 17.6 15.3% to 20.1% 114 16.2 10.8% to 23.5% 28 24.3 12.8% to 41.4% 933 17.7 15.5% to 19.9%
BMI, body mass index; HDL, high-density lipoprotein.
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then removed to increase parsimony and a few add-
itional paths were added to improve model ﬁt.
Speciﬁcally, we dropped consanguinity and smoking
status as variables and added the following correlations:
HEI fruit score and educational status; HEI fruit score
and vegetable score; prevalence of eating out versus
eating fast food per week; HEI vegetable score and edu-
cational status; and total cholesterol and triglycerides.
We also added correlations between weekly hours of
moderate and vigorous physical activity at work. All
items depicting the latent variables of physical activity,
diet and sociodemographic characteristics had signiﬁ-
cant factor loadings, except for smoking status. The ﬁnal
model had excellent ﬁt (CFI 0.971; RMSEA 0.032;
WRMR 1.253) and the fully standardized path coefﬁ-
cients are presented in ﬁgure 2. We report pathways only
for statistically signiﬁcant standardized path coefﬁcients
at the p<0.05 level (ﬁgure 3).
The two risk factors deemed to have a direct statistic-
ally signiﬁcant effect on type 2 diabetes and pre-diabetes
statuses were triglycerides (0.336) and BMI (0.164).
Sociodemographic background had a strong negative
effect both on diet (−0.522) and BMI (−0.352). Total
cholesterol had a positive effect on BMI (0.134). Diet
had in turn an important positive effect on triglycerides
(0.281). Physical activity had a negative effect on BMI
(−0.148) and a positive effect on HDL (0.106). HDL
had a strong positive effect on total cholesterol (0.230)
and a negative effect on triglycerides (−0.128), BMI
(−0.108) and waist circumference (−0.104). Family
history of diabetes was found to have a negative effect
on total cholesterol (−0.104). In addition, waist circum-
ference had a negative effect on hypertensive status
(−0.221); in contrast, BMI had a very strong positive
effect (0.788) on waist circumference.
There are speciﬁc indirect effects between sociodemo-
graphic background and diabetes status, which are
mediated by diet and tryglyceride levels (−0.049;
p=0.007) and BMI (−0.058; p=0.001). Triglycerides also
mediated the indirect effects between diet and diabetes
status (0.095; p<0.000). We also found an indirect effect
between physical activity and diabetes status that was
mediated by BMI (−0.024; p=0.009), HDL and BMI
(−0.002; p=0.049) and HDL and tryglycerides (−0.005;
p=0.043). Important correlations found and added post
hoc to the ﬁnal model were weekly prevalence of eating
out and weekly fast food consumption (0.353), as well as
educational status and HEI vegetable score (0.166) and
HEI fruit score (0.199). In addition, we found correla-
tions between HEI vegetable score and HEI fruit score
(0.299), moderate and vigorous physical activity at work
(0.323) and total cholesterol and triglycerides (0.417).
All results from our SEM analysis are reported in table 3.
CONCLUSIONS
To the best of our knowledge, this is the ﬁrst study to
use SEM to analyze modiﬁable behavioral and metabolic
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determinants for diabetes status in a Middle Eastern
country. The primary ﬁnding of the study is that trigly-
cerides and BMI have a critical effect on diabetes status
as independent risk factors for type 2 diabetes.
Tryglycerides were also found to mediate the effects that
diet, physical activity and sociodemographic background
have on diabetes status. These results reinforce the ﬁnd-
ings from studies44 45 showing that triglycerides and BMI
are not only the common characteristics of the dyslipide-
mia associated with insulin resistance and type 2 dia-
betes, but are also the link between the central
pathophysiological feature of a diabetic’s abnormal lipid
Figure 3 Indirect effects of
factors for diabetes in the
STEPwise approach to
surveillance 2012 survey—Qatar
among adults aged 18–64 years.
Ellipse indicates latent,
unobservable constructs; box
indicates observed variable;
curved line with one arrowhead
denotes indirect effect. Adjusted
for sex and age. BMI, body mass
index; HDL, high-density
lipoprotein; HEI, Healthy Eating
Index; PA, physical activity.
Figure 2 Final model of factors for diabetes in the STEPwise approach to surveillance 2012 survey—Qatar among adults aged
18–64 years. Ellipse indicates latent, unobservable constructs; box indicates observed variable; straight line with one arrowhead
denotes direct effect; curved line denotes correlation. Adjusted for sex and age.
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proﬁle and modiﬁable behavioral variables such as diet
and physical activity.46 47 Some evidence also suggests
that fasting triglyceride levels can aid in predicting tran-
sition to type 2 diabetes.48 For this reason, adequate
control of triglycerides has been proposed as a thera-
peutic goal in the metabolic control of subjects with pre-
diabetes and type 2 diabetes. Our study ﬁndings that tri-
glycerides are strongly linked to dietary quality support
this proposal in an Arabic context.18
The second crucial ﬁnding of this study is that BMI
has a direct positive effect on diabetes status. The most
inﬂuential factor affecting BMI is the negative
association with sociodemographic background, which
links social determinants of health such as education
and marital status to abnormal metabolic control
leading to obesity. This result matches ﬁndings from pre-
vious research, which showed that sociodemographic
factors are linked to dietary intake, metabolic risk and
high BMI.49 Our model also identiﬁed a negative effect
between physical activity and BMI that is consistent with
studies of speciﬁc type 2 diabetes risk factors.32 Higher
levels of physical activity are associated with lower BMI.
Furthermore, total cholesterol was directly affected by a
family history of diabetes. Family history of diabetes can
Table 3 Statistically significant latent variable factor structure, direct effects and correlations of the final SEM model
Latent variables Estimate SE Est./SE
Two-tailed
p value
Hours of vigorous PA at work → PA 0.207 0.013 16.0 0.000
Hours of moderate PA at work → PA 0.240 0.020 11.7 0.000
Hours of walking→ PA 0.689 0.024 28.5 0.000
Hours of vigorous PA doing sports→ PA 0.594 0.022 26.7 0.000
Hours of moderate PA doing sports → PA 0.256 0.011 23.0 0.000
HEI fruit score→ Diet 0.277 0.042 6.7 0.000
HEI vegetable score→ Diet 0.168 0.042 3.9 0.000
Eat out prevalence→ Diet −0.449 0.051 −8.9 0.000
Fast food prevalence→ Diet −0.453 0.047 −9.6 0.000
Educational status→ Sociodemographic background 0.150 0.041 3.7 0.000
Marital status→ Sociodemographic background −0.850 0.048 −17.8 0.000
Direct effects
Sociodemographic background→ Diet −0.522 0.132 −3.95 0.000
PA→ HDL 0.106 0.029 3.67 0.000
PA→ BMI −0.148 0.036 −4.16 0.000
Sociodemographic background→ BMI −0.352 0.039 −9.09 0.000
Diet→ Triglycerides 0.281 0.064 4.425 0.000
HDL→ BMI −0.108 0.038 −2.88 0.004
Total cholesterol→ BMI 0.134 0.051 2.62 0.009
HDL→ Triglycerides −0.128 0.049 −2.63 0.009
HDL→ Total cholesterol 0.230 0.048 4.79 0.000
Family history of diabetes→ Total cholesterol −0.104 0.047 −2.23 0.026
Triglycerides→ FBG 0.336 0.057 5.87 0.000
BMI FBG 0.164 0.047 3.46 0.001
HDL→ Waist circumference −0.104 0.033 −3.14 0.002
BMI→ Waist circumference 0.788 0.016 49.07 0.000
Waist circumference→ High blood pressure −0.221 0.048 4.58 0.000
Specific indirect effects
PA→BMI→FBG −0.024 0.009 −2.62 0.009
PA→HDL→BMI→FBG −0.002 0.001 −1.97 0.049
PA→HDL→ Triglycerides →FBG −0.005 0.002 −2.02 0.043
Sociodemographic background→BMI→FBG −0.058 0.018 −3.23 0.001
Sociodemographic background→Diet→ Triglycerides→ FBG −0.049 0.018 −2.72 0.007
Diet→ Triglycerides→ FBG 0.095 0.027 3.52 0.000
Correlations
Hours of moderate PA at work Hours of vigorous PA at work 0.323 0.011 29.45 0.000
Educational status HEI fruit score 0.199 0.033 6.02 0.000
HEI vegetable score HEI fruit score 0.299 0.035 8.62 0.000
Fast food prevalence Eat out prevalence 0.353 0.033 10.71 0.000
Educational status HEI vegetable score 0.166 0.035 4.79 0.000
Total cholesterol Triglycerides 0.417 0.063 6.64 0.000
BMI, body mass index; Est, estimates; FBG, fasting blood glucose; HDL, high-density lipoprotein; HEI, Healthy Eating Index; PA, physical
activity; SEM, structural equation model.
BMJ Open Diabetes Research and Care 2016;4:e000231. doi:10.1136/bmjdrc-2016-000231 9
Epidemiology/health services research
be genetic and/or environmental and has been linked to
obesity, hyperlipidemia, abnormal metabolic control and
risk for type 2 diabetes.9 Consistent with our ﬁndings, a
review of genomic studies reiterated that signiﬁcant
gene–diet and gene–environment interactions result in
altered lipid metabolism, inﬂammation and other meta-
bolic imbalances that lead to cardiovascular disease and
obesity.50 We found that the genetic and behavioral
effects of sociodemographic factors, diet and physical
activity levels on BMI and lipid proﬁle (expressed in low
HDL and high triglyceride values) tend to mediate the
metabolic effects of obesity on diabetes status.
One shortcoming of the Qatar STEPS survey is that it
did not collect income data or alcohol consumption
data from its respondents and we were unable to
explore the links between diabetes and income status
and diabetes and alcohol consumption. Further research
into the links between socioeconomic status and type 2
diabetes in Qatar would be beneﬁcial. In addition, the
STEPS dietary intake data are limited to fruits and vege-
tables, which may bias dietary inputs that might inﬂu-
ence metabolic risk and obesity. This might be one of
the reasons why diet did not have a statistically signiﬁ-
cant effect on BMI or diabetes status. Inclusion of com-
prehensive dietary intake variables in future Qatari
health surveys might be helpful in determining the links
between dietary inputs, metabolism and obesity.
Another concern is that the link between triglyceridemia
and diabetes status is inﬂuenced by the fed–fasted state,
insulin sensitivity and lifestyle factors. Triglyceride levels
are a sensitive lifestyle biomarker and determination at a
single time point may inaccurately reﬂect long-term tri-
glyceridemia. This is also the case for other biomarkers
used to populate our hypothesized model such as HDL.
Our main outcome measure (FBG), also deﬁned dia-
betes status according to only a single point in time
when in reality FBG can naturally ﬂuctuate. As a result,
we acknowledge that the lack of a second conﬁrmatory
FBG measure may bias our estimates. A ﬁnal limitation
of this study is the cross-sectional nature of the STEPS
survey, which prevents us from making causal inferences
about diabetes status. Ideally our model would include
longitudinal outcomes because they would be able to
show how risk factors affecting type 2 diabetes transition
evolve in time. Nonetheless, our study is a valuable
initial step in furthering diabetes research in a highly
affected region that has limited access to relevant data.
Future research could build on our work by disentan-
gling what affects different risk factors in time and their
individual contribution to type 2 diabetes transition.
Our model of risk for type 2 diabetes in Qatar con-
ﬁrms previously established associations of modiﬁable
factors such as physical activity and BMI with type 2 dia-
betes status. Our results also provide evidence that type
2 diabetes mellitus can be prevented with behavioral
changes in the lifestyles of those at high risk for develop-
ing the disease. As part of Qatar’s National Health
Insurance Scheme a diabetes disease management
program was launched last year with the aim of improv-
ing outcomes, controlling diabetes and offering preven-
tion education. In line with this initiative, further
research on diabetes in Qatar and the Middle East
region should focus on the preventive roles that patients,
families and physicians have within the healthcare
system. Preventive roles need to be incorporated into a
primary healthcare model grounded on an integrated
system of diabetes prevention that is based on patient
welfare and personalized care. As more Qataris develop
type 2 diabetes, the population will spend increasing
periods of time living with the debilitating complications
of the disease. This adds considerable urgency to public
policy deliberations on the matter. Effective implementa-
tion of primary prevention of type 2 diabetes mellitus
represents a unique opportunity to reduce the burden
of diabetes and its complications.
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